Drugs & Targets FDA Approves Gazyva Plus Bendamustine for Patients with Follicular Lymphoma February 29, 2016Vol.39 No.02
Halaven Study Improves Overall Survival In Liposarcomas and Leiomyosarcomas February 29, 2016Vol.39 No.02
Phase III Blincyto Study in Leukemia Stopped Early After Meeting OS Primary Endpoint February 29, 2016Vol.39 No.02
Drugs & Targets Opdivo-Yervoy Combination Granted Accelerated Approval in Metastatic Melanoma February 01, 2016Vol.39 No.01
Analysis Evaluates Moore Criteria for Bevacizumab Effectiveness in Cervical Cancer February 01, 2016Vol.39 No.01
Vectibix Meets Primary Endpoint In Phase III Wild-Type KRAS Colorectal Cancer Trial February 01, 2016Vol.39 No.01
Trial of 200,000 Women Shows Screening Can Reduce Ovarian Cancer Mortality by 20 Percent February 01, 2016Vol.39 No.01
Survey of Breast Cancer Cell Function Identifies New Drug Uses, Combinations February 01, 2016Vol.39 No.01
Phase III Trial Binimetinib Increases PFS in NRAS-Mutant Melanoma vs. Dacarbazine February 01, 2016Vol.39 No.01
